Osteoarthritis Trial, Recruiting (NCT07439575)

Osteoarthritis Trial, Recruiting NCT07439575 Sponsor: Bahattin Kemah Condition: Osteoarthritis

Printed from Voxsanity (voxsanity.com.au) — NCT07439575 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoarthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 30 years of age or older
People who are scheduled to have a new total hip or knee replacement for the first time
People who are scheduled to have a revision (repeat) hip or knee replacement surgery for non-infection-related reasons
People whose surgery will be carried out by the same surgical team involved in the trial
People who are able to give their informed consent to participate

Who may not be able to join:

People who are under 30 years of age
People who are currently taking medications that suppress the immune system
People who have diabetes with serious or complex complications
People who have a condition where the veins in their legs do not work properly (chronic venous insufficiency)
People who have poor blood flow in the arteries of their legs or feet (peripheral arterial disease)
People who need a hip or knee replacement because of cancer
People who have a current or previous infection at a surgical wound site

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bahattin Kemah, MD, Umraniye Education and Research Hospital

Phone: +905337198121

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07439575

Sponsor: Bahattin Kemah

Phase: Not Applicable

Status: Recruiting

Condition: Osteoarthritis

Trial contact: +905337198121

More information: https://clinicaltrials.gov/study/NCT07439575

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 30 years of age or older
People who are scheduled to have a new total hip or knee replacement for the first time
People who are scheduled to have a revision (repeat) hip or knee replacement surgery for non-infection-related reasons
People whose surgery will be carried out by the same surgical team involved in the trial
People who are able to give their informed consent to participate

Who may not be able to join:

People who are under 30 years of age
People who are currently taking medications that suppress the immune system
People who have diabetes with serious or complex complications
People who have a condition where the veins in their legs do not work properly (chronic venous insufficiency)
People who have poor blood flow in the arteries of their legs or feet (peripheral arterial disease)
People who need a hip or knee replacement because of cancer
People who have a current or previous infection at a surgical wound site

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Bahattin Kemah

Registry

ClinicalTrials.gov

Start date

1 November 2025

Est. completion

1 August 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Incidence of wound-related complications within 90 days postoperatively

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov